1
|
Vörös D, Kiss O, Taigiszer M, László BR, Ollmann T, Péczely L, Zagorácz O, Kertes E, Kállai V, Berta B, Kovács A, Karádi Z, Lénárd L, László K. The role of intraamygdaloid oxytocin in spatial learning and avoidance learning. Peptides 2024; 175:171169. [PMID: 38340898 DOI: 10.1016/j.peptides.2024.171169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/08/2023] [Revised: 01/26/2024] [Accepted: 02/06/2024] [Indexed: 02/12/2024]
Abstract
The goal of the present study is to investigate the role of intraamygdaloid oxytocin in learning-related mechanisms. Oxytocin is a neuropeptide which is involved in social bonding, trust, emotional responses and various social behaviors. By conducting passive avoidance and Morris water maze tests on male Wistar rats, the role of intraamygdaloid oxytocin in memory performance and learning was investigated. Oxytocin doses of 10 ng and 100 ng were injected into the central nucleus of the amygdala. Our results showed that 10 ng oxytocin significantly reduced the time required to locate the platform during the Morris water maze test while significantly increasing the latency time in the passive avoidance test. However, the 100 ng oxytocin experiment failed to produce a significant effect in either of the tests. Wistar rats pretreated with 20 ng oxytocin receptor antagonist (L-2540) were administered 10 ng of oxytocin into the central nucleus of the amygdala and were also subjected to the aforementioned tests to highlight the role of oxytocin receptors in spatial- and avoidance learning. Results suggest that oxytocin supports memory processing during both the passive avoidance and the Morris water maze tests. Oxytocin antagonists can however block the effects of oxytocin in both tests. The results substantiate that oxytocin uses oxytocin receptors to enhance memory and learning performance.
Collapse
Affiliation(s)
- Dávid Vörös
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, P.O. Box 99, 7602 Pécs, Hungary; Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
| | - Orsolya Kiss
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, P.O. Box 99, 7602 Pécs, Hungary; Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
| | - Márton Taigiszer
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, P.O. Box 99, 7602 Pécs, Hungary; Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
| | - Bettina Réka László
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, P.O. Box 99, 7602 Pécs, Hungary; Neuroscience Center, University of Pécs, 7602 Pécs, Hungary
| | - Tamás Ollmann
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, P.O. Box 99, 7602 Pécs, Hungary; Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary; Neuroscience Center, University of Pécs, 7602 Pécs, Hungary; Learning in Biological and Artificial Systems Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
| | - László Péczely
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, P.O. Box 99, 7602 Pécs, Hungary; Neuroscience Center, University of Pécs, 7602 Pécs, Hungary; Learning in Biological and Artificial Systems Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
| | - Olga Zagorácz
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, P.O. Box 99, 7602 Pécs, Hungary; Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary; Neuroscience Center, University of Pécs, 7602 Pécs, Hungary; Learning in Biological and Artificial Systems Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
| | - Erika Kertes
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, P.O. Box 99, 7602 Pécs, Hungary; Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary; Neuroscience Center, University of Pécs, 7602 Pécs, Hungary; Learning in Biological and Artificial Systems Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
| | - Veronika Kállai
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, P.O. Box 99, 7602 Pécs, Hungary; Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary; Neuroscience Center, University of Pécs, 7602 Pécs, Hungary; Learning in Biological and Artificial Systems Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
| | - Beáta Berta
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, P.O. Box 99, 7602 Pécs, Hungary; Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary; Neuroscience Center, University of Pécs, 7602 Pécs, Hungary; Learning in Biological and Artificial Systems Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
| | - Anita Kovács
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, P.O. Box 99, 7602 Pécs, Hungary; Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary; Neuroscience Center, University of Pécs, 7602 Pécs, Hungary
| | - Zoltán Karádi
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, P.O. Box 99, 7602 Pécs, Hungary; Neuroscience Center, University of Pécs, 7602 Pécs, Hungary; Cellular Bioimpedance Research Group, Szentágothai Research Center, University of Pécs, 7602 Pécs, Hungary; Molecular Endocrinology and Neurophysiology Research Group, Szentágothai Center, University of Pécs, 7602 Pécs, Hungary
| | - László Lénárd
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, P.O. Box 99, 7602 Pécs, Hungary; Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary; Neuroscience Center, University of Pécs, 7602 Pécs, Hungary; Molecular Endocrinology and Neurophysiology Research Group, Szentágothai Center, University of Pécs, 7602 Pécs, Hungary
| | - Kristóf László
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, P.O. Box 99, 7602 Pécs, Hungary; Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary; Neuroscience Center, University of Pécs, 7602 Pécs, Hungary.
| |
Collapse
|
2
|
Vörös D, Kiss O, Ollmann T, Mintál K, Péczely L, Zagoracz O, Kertes E, Kállai V, László BR, Berta B, Toth A, Lénárd L, László K. Intraamygdaloid Oxytocin Increases Time Spent on Social Interaction in Valproate-Induced Autism Animal Model. Biomedicines 2023; 11:1802. [PMID: 37509444 PMCID: PMC10376246 DOI: 10.3390/biomedicines11071802] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2023] [Revised: 06/16/2023] [Accepted: 06/17/2023] [Indexed: 07/30/2023] Open
Abstract
Autism spectrum disorder (ASD) is a pervasive neurodevelopmental disorder that affects about 1.5% of children worldwide. One of the core symptoms is impaired social interaction. Since proper treatment has not been found yet, an investigation of the exact pathophysiology of autism is essential. The valproate (VPA)-induced rat model can be an appropriate way to study autism. Oxytocin (OT) may amend some symptoms of ASD since it plays a key role in developing social relationships. In the present study, we investigated the effect of the intraamygdaloid OT on sham and intrauterine VPA-treated rats' social interaction using Crawley's social interaction test. Bilateral guide cannulae were implanted above the central nucleus of the amygdala (CeA), and intraamygdaloid microinjections were carried out before the test. Our results show that male Wistar rats prenatally exposed to VPA spent significantly less time on social interaction. Bilateral OT microinjection increased the time spent in the social zone; it also reached the level of sham-control animals. OT receptor antagonist blocked this effect of the OT but in itself did not significantly influence the behavior of the rats. Based on our results, we can establish that intraamygdaloid OT has significantly increased time spent on social interaction in the VPA-induced autism model, and its effect is receptor-specific.
Collapse
Affiliation(s)
- Dávid Vörös
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, 7602 Pécs, Hungary
- Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
| | - Orsolya Kiss
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, 7602 Pécs, Hungary
- Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
| | - Tamás Ollmann
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, 7602 Pécs, Hungary
- Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
- Neuroscience Center, University of Pécs, 7602 Pécs, Hungary
- Learning in Biological and Artificial Systems Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
| | - Kitti Mintál
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, 7602 Pécs, Hungary
- Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
- Cellular Bioimpedance Research Group, Szentágothai Research Center, University of Pécs, 7602 Pécs, Hungary
| | - László Péczely
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, 7602 Pécs, Hungary
- Neuroscience Center, University of Pécs, 7602 Pécs, Hungary
- Learning in Biological and Artificial Systems Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
| | - Olga Zagoracz
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, 7602 Pécs, Hungary
- Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
- Neuroscience Center, University of Pécs, 7602 Pécs, Hungary
- Learning in Biological and Artificial Systems Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
| | - Erika Kertes
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, 7602 Pécs, Hungary
- Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
- Neuroscience Center, University of Pécs, 7602 Pécs, Hungary
- Learning in Biological and Artificial Systems Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
| | - Veronika Kállai
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, 7602 Pécs, Hungary
- Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
- Neuroscience Center, University of Pécs, 7602 Pécs, Hungary
- Learning in Biological and Artificial Systems Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
| | - Bettina Réka László
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, 7602 Pécs, Hungary
- Neuroscience Center, University of Pécs, 7602 Pécs, Hungary
| | - Beáta Berta
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, 7602 Pécs, Hungary
- Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
- Neuroscience Center, University of Pécs, 7602 Pécs, Hungary
- Learning in Biological and Artificial Systems Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
| | - Attila Toth
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, 7602 Pécs, Hungary
- Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
- Neuroscience Center, University of Pécs, 7602 Pécs, Hungary
- Cellular Bioimpedance Research Group, Szentágothai Research Center, University of Pécs, 7602 Pécs, Hungary
| | - László Lénárd
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, 7602 Pécs, Hungary
- Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
- Neuroscience Center, University of Pécs, 7602 Pécs, Hungary
- Molecular Endocrinology and Neurophysiology Research Group, Szentágothai Center, University of Pécs, 7602 Pécs, Hungary
| | - Kristóf László
- Medical School, Institute of Physiology, University of Pécs, Szigeti Str. 12, 7602 Pécs, Hungary
- Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Medical School, Institute of Physiology, University of Pécs, 7602 Pécs, Hungary
- Neuroscience Center, University of Pécs, 7602 Pécs, Hungary
| |
Collapse
|
3
|
Dusa D, Ollmann T, Kállai V, Lénárd L, Kertes E, Berta B, Szabó Á, László K, Gálosi R, Zagoracz O, Karádi Z, Péczely L. The antipsychotic drug sulpiride in the ventral pallidum paradoxically impairs learning and induces place preference. Sci Rep 2022; 12:19247. [PMID: 36357539 PMCID: PMC9649625 DOI: 10.1038/s41598-022-23450-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2022] [Accepted: 10/31/2022] [Indexed: 11/12/2022] Open
Abstract
Sulpiride, as a D2-like dopamine (DA) receptor (D2R) antagonist, is an important antipsychotic drug in the treatment of schizophrenia. Recently, we have shown that the activation of D2Rs in the ventral pallidum (VP) modulates the activity of the ventral tegmental area (VTA) DAergic neurons. According to our hypothesis, intra-VP sulpiride can influence the motivational and learning processes, pervasively modifying the behavior of examined animals. In the present study, sulpiride was microinjected into the VP of male Wistar rats in three different doses. Morris water maze (MWM) test was applied to investigate the effects of sulpiride on spatial learning, while conditioned place preference (CPP) test was used to examine the potential rewarding effect of the drug. In order to show, whether the animals can associate the rewarding effect with an area which can be recognized only on its spatial location, we introduced a modified version of the CPP paradigm, the spatial CPP test. Our results show that the intra-VP sulpiride dose-dependently impairs learning processes. However, the largest dose of sulpiride induces place preference. Results of the spatial CPP paradigm demonstrate that the animals cannot associate the rewarding effect of the drug with the conditioning area based on its spatial location. In the CPP paradigm, locomotor activity decrease could be observed in the sulpiride-treated rats, likely because of a faster habituation with the conditioning environment. In summary, we can conclude that intra-VP sulpiride has a dual effect: it diminishes the hippocampus-dependent spatial learning processes, in addition, it has a dose-dependent rewarding effect.
Collapse
Affiliation(s)
- Daniella Dusa
- grid.9679.10000 0001 0663 9479Learning in Biological and Artificial Systems Research Group, Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary ,grid.9679.10000 0001 0663 9479Institute of Physiology, Medical School, University of Pécs, Szigeti Str. 12, P.O. Box: 99, Pécs, 7602 Hungary ,grid.9679.10000 0001 0663 9479Centre for Neuroscience, University of Pécs, Pécs, Hungary
| | - Tamás Ollmann
- grid.9679.10000 0001 0663 9479Learning in Biological and Artificial Systems Research Group, Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary ,grid.9679.10000 0001 0663 9479Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary ,grid.9679.10000 0001 0663 9479Institute of Physiology, Medical School, University of Pécs, Szigeti Str. 12, P.O. Box: 99, Pécs, 7602 Hungary ,grid.9679.10000 0001 0663 9479Centre for Neuroscience, University of Pécs, Pécs, Hungary
| | - Veronika Kállai
- grid.9679.10000 0001 0663 9479Learning in Biological and Artificial Systems Research Group, Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary ,grid.9679.10000 0001 0663 9479Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary ,grid.9679.10000 0001 0663 9479Institute of Physiology, Medical School, University of Pécs, Szigeti Str. 12, P.O. Box: 99, Pécs, 7602 Hungary ,grid.9679.10000 0001 0663 9479Centre for Neuroscience, University of Pécs, Pécs, Hungary
| | - László Lénárd
- grid.9679.10000 0001 0663 9479Institute of Physiology, Medical School, University of Pécs, Szigeti Str. 12, P.O. Box: 99, Pécs, 7602 Hungary ,grid.9679.10000 0001 0663 9479Molecular Neuroendocrinology and Neurophysiology Research Group, Szentágothai Research Centre, University of Pécs, Pécs, Hungary ,grid.9679.10000 0001 0663 9479Centre for Neuroscience, University of Pécs, Pécs, Hungary
| | - Erika Kertes
- grid.9679.10000 0001 0663 9479Learning in Biological and Artificial Systems Research Group, Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary ,grid.9679.10000 0001 0663 9479Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary ,grid.9679.10000 0001 0663 9479Institute of Physiology, Medical School, University of Pécs, Szigeti Str. 12, P.O. Box: 99, Pécs, 7602 Hungary ,grid.9679.10000 0001 0663 9479Centre for Neuroscience, University of Pécs, Pécs, Hungary
| | - Beáta Berta
- grid.9679.10000 0001 0663 9479Learning in Biological and Artificial Systems Research Group, Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary ,grid.9679.10000 0001 0663 9479Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary ,grid.9679.10000 0001 0663 9479Institute of Physiology, Medical School, University of Pécs, Szigeti Str. 12, P.O. Box: 99, Pécs, 7602 Hungary ,grid.9679.10000 0001 0663 9479Centre for Neuroscience, University of Pécs, Pécs, Hungary
| | - Ádám Szabó
- grid.9679.10000 0001 0663 9479Learning in Biological and Artificial Systems Research Group, Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary ,grid.9679.10000 0001 0663 9479Institute of Physiology, Medical School, University of Pécs, Szigeti Str. 12, P.O. Box: 99, Pécs, 7602 Hungary
| | - Kristóf László
- grid.9679.10000 0001 0663 9479Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary ,grid.9679.10000 0001 0663 9479Institute of Physiology, Medical School, University of Pécs, Szigeti Str. 12, P.O. Box: 99, Pécs, 7602 Hungary ,grid.9679.10000 0001 0663 9479Centre for Neuroscience, University of Pécs, Pécs, Hungary
| | - Rita Gálosi
- grid.9679.10000 0001 0663 9479Institute of Physiology, Medical School, University of Pécs, Szigeti Str. 12, P.O. Box: 99, Pécs, 7602 Hungary ,grid.9679.10000 0001 0663 9479Centre for Neuroscience, University of Pécs, Pécs, Hungary
| | - Olga Zagoracz
- grid.9679.10000 0001 0663 9479Neuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary ,grid.9679.10000 0001 0663 9479Institute of Physiology, Medical School, University of Pécs, Szigeti Str. 12, P.O. Box: 99, Pécs, 7602 Hungary ,grid.9679.10000 0001 0663 9479Centre for Neuroscience, University of Pécs, Pécs, Hungary
| | - Zoltán Karádi
- grid.9679.10000 0001 0663 9479Institute of Physiology, Medical School, University of Pécs, Szigeti Str. 12, P.O. Box: 99, Pécs, 7602 Hungary ,grid.9679.10000 0001 0663 9479Molecular Neuroendocrinology and Neurophysiology Research Group, Szentágothai Research Centre, University of Pécs, Pécs, Hungary ,grid.9679.10000 0001 0663 9479Centre for Neuroscience, University of Pécs, Pécs, Hungary
| | - László Péczely
- grid.9679.10000 0001 0663 9479Learning in Biological and Artificial Systems Research Group, Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary ,grid.9679.10000 0001 0663 9479Institute of Physiology, Medical School, University of Pécs, Szigeti Str. 12, P.O. Box: 99, Pécs, 7602 Hungary ,grid.9679.10000 0001 0663 9479Centre for Neuroscience, University of Pécs, Pécs, Hungary
| |
Collapse
|
4
|
Ollmann T, Lénárd L, Péczely L, Berta B, Kertes E, Zagorácz O, Hormay E, László K, Szabó Á, Gálosi R, Karádi Z, Kállai V. Effect of D1- and D2-like Dopamine Receptor Antagonists on the Rewarding and Anxiolytic Effects of Neurotensin in the Ventral Pallidum. Biomedicines 2022; 10:biomedicines10092104. [PMID: 36140205 PMCID: PMC9495457 DOI: 10.3390/biomedicines10092104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2022] [Revised: 08/24/2022] [Accepted: 08/25/2022] [Indexed: 12/04/2022] Open
Abstract
Background: Neurotensin (NT) acts as a neurotransmitter and neuromodulator in the central nervous system. It was shown previously that NT in the ventral pallidum (VP) has rewarding and anxiolytic effects. NT exerts its effect in interaction with dopamine (DA) receptors in numerous brain areas; however, this has not yet been investigated in the VP. The aim of this study was to examine whether the inhibition of D1-like and D2-like DA receptors of the VP can modify the above mentioned effects of NT. Methods: Microinjection cannulas were implanted by means of stereotaxic operations into the VP of male Wistar rats. The rewarding effect of NT was examined by means of a conditioned place preference test. Anxiety was investigated with an elevated plus maze test. To investigate the possible interaction, D1-like DA receptor antagonist SCH23390 or D2-like DA receptor antagonist sulpiride were microinjected prior to NT. All of the drugs were also injected independently to analyze their effects alone. Results: In the present experiments, both the rewarding and anxiolytic effects of NT in the VP were prevented by both D1-like and D2-like DA receptor antagonists. Administered on their own, the antagonists did not influence reward and anxiety. Conclusion: Our present results show that the activity of the D1-like and D2-like DA receptors of the VP is a necessary requirement for both the rewarding and anxiolytic effects of NT.
Collapse
Affiliation(s)
- Tamás Ollmann
- Institute of Physiology, Medical School, University of Pécs, H-7624 Pécs, Hungary
- Centre for Neuroscience, University of Pécs, H-7624 Pécs, Hungary
- Correspondence: ; Tel.: +36-72-536000 (ext. 31095)
| | - László Lénárd
- Institute of Physiology, Medical School, University of Pécs, H-7624 Pécs, Hungary
- Centre for Neuroscience, University of Pécs, H-7624 Pécs, Hungary
- Molecular Neuroendocrinology and Neurophysiology Research Group, Szentágothai Center, University of Pécs, H-7624 Pécs, Hungary
| | - László Péczely
- Institute of Physiology, Medical School, University of Pécs, H-7624 Pécs, Hungary
- Centre for Neuroscience, University of Pécs, H-7624 Pécs, Hungary
| | - Beáta Berta
- Institute of Physiology, Medical School, University of Pécs, H-7624 Pécs, Hungary
- Centre for Neuroscience, University of Pécs, H-7624 Pécs, Hungary
| | - Erika Kertes
- Institute of Physiology, Medical School, University of Pécs, H-7624 Pécs, Hungary
- Centre for Neuroscience, University of Pécs, H-7624 Pécs, Hungary
| | - Olga Zagorácz
- Institute of Physiology, Medical School, University of Pécs, H-7624 Pécs, Hungary
- Centre for Neuroscience, University of Pécs, H-7624 Pécs, Hungary
| | - Edina Hormay
- Institute of Physiology, Medical School, University of Pécs, H-7624 Pécs, Hungary
- Centre for Neuroscience, University of Pécs, H-7624 Pécs, Hungary
| | - Kristóf László
- Institute of Physiology, Medical School, University of Pécs, H-7624 Pécs, Hungary
- Centre for Neuroscience, University of Pécs, H-7624 Pécs, Hungary
| | - Ádám Szabó
- Institute of Physiology, Medical School, University of Pécs, H-7624 Pécs, Hungary
- Centre for Neuroscience, University of Pécs, H-7624 Pécs, Hungary
| | - Rita Gálosi
- Institute of Physiology, Medical School, University of Pécs, H-7624 Pécs, Hungary
- Centre for Neuroscience, University of Pécs, H-7624 Pécs, Hungary
| | - Zoltán Karádi
- Institute of Physiology, Medical School, University of Pécs, H-7624 Pécs, Hungary
- Centre for Neuroscience, University of Pécs, H-7624 Pécs, Hungary
- Molecular Neuroendocrinology and Neurophysiology Research Group, Szentágothai Center, University of Pécs, H-7624 Pécs, Hungary
| | - Veronika Kállai
- Institute of Physiology, Medical School, University of Pécs, H-7624 Pécs, Hungary
- Centre for Neuroscience, University of Pécs, H-7624 Pécs, Hungary
| |
Collapse
|
5
|
László K, Kiss O, Vörös D, Mintál K, Ollmann T, Péczely L, Kovács A, Zagoracz O, Kertes E, Kállai V, László B, Hormay E, Berta B, Tóth A, Karádi Z, Lénárd L. Intraamygdaloid Oxytocin Reduces Anxiety in the Valproate-Induced Autism Rat Model. Biomedicines 2022; 10:biomedicines10020405. [PMID: 35203614 PMCID: PMC8962302 DOI: 10.3390/biomedicines10020405] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2022] [Revised: 01/26/2022] [Accepted: 01/31/2022] [Indexed: 12/10/2022] Open
Abstract
Background: Autism spectrum disorder (ASD) is a lifelong neurodevelopmental disorder affecting about 1.5% of children, and its prevalence is increasing. Anxiety is one of the most common comorbid signs of ASD. Despite the increasing prevalence, the pathophysiology of ASD is still poorly understood, and its proper treatment has not been defined yet. In order to develop new therapeutic approaches, the valproate- (VPA) induced rodent model of autism can be an appropriate tool. Oxytocin (OT), as a prosocial hormone, may ameliorate some symptoms of ASD. Methods: In the present study, we investigated the possible anxiolytic effect of intraamygdaloid OT on VPA-treated rats using the elevated plus maze test. Results: Our results show that male Wistar rats prenatally exposed to VPA spent significantly less time in the open arms of the elevated plus maze apparatus and performed significantly less head dips from the open arms. Bilateral OT microinjection into the central nucleus of the amygdala increased the time spent in the open arms and the number of head dips and reduced the anxiety to the healthy control level. An OT receptor antagonist blocked the anxiolytic effects of OT. The antagonist by itself did not influence the time rats spent in the open arms. Conclusions: Our results show that intraamygdaloid OT has anxiolytic effects in autistic rats.
Collapse
Affiliation(s)
- Kristóf László
- Medical School, Institute of Physiology, University of Pécs, 7624 Pécs, Hungary; (O.K.); (D.V.); (K.M.); (T.O.); (L.P.); (A.K.); (O.Z.); (E.K.); (V.K.); (B.L.); (E.H.); (B.B.); (A.T.); (Z.K.); (L.L.)
- Neuroscience Center, University of Pécs, 7624 Pécs, Hungary
- Correspondence: ; Tel.: +36-72-53624; Fax: +36-72-536244
| | - Orsolya Kiss
- Medical School, Institute of Physiology, University of Pécs, 7624 Pécs, Hungary; (O.K.); (D.V.); (K.M.); (T.O.); (L.P.); (A.K.); (O.Z.); (E.K.); (V.K.); (B.L.); (E.H.); (B.B.); (A.T.); (Z.K.); (L.L.)
- Neuroscience Center, University of Pécs, 7624 Pécs, Hungary
| | - Dávid Vörös
- Medical School, Institute of Physiology, University of Pécs, 7624 Pécs, Hungary; (O.K.); (D.V.); (K.M.); (T.O.); (L.P.); (A.K.); (O.Z.); (E.K.); (V.K.); (B.L.); (E.H.); (B.B.); (A.T.); (Z.K.); (L.L.)
- Neuroscience Center, University of Pécs, 7624 Pécs, Hungary
| | - Kitti Mintál
- Medical School, Institute of Physiology, University of Pécs, 7624 Pécs, Hungary; (O.K.); (D.V.); (K.M.); (T.O.); (L.P.); (A.K.); (O.Z.); (E.K.); (V.K.); (B.L.); (E.H.); (B.B.); (A.T.); (Z.K.); (L.L.)
- Neuroscience Center, University of Pécs, 7624 Pécs, Hungary
| | - Tamás Ollmann
- Medical School, Institute of Physiology, University of Pécs, 7624 Pécs, Hungary; (O.K.); (D.V.); (K.M.); (T.O.); (L.P.); (A.K.); (O.Z.); (E.K.); (V.K.); (B.L.); (E.H.); (B.B.); (A.T.); (Z.K.); (L.L.)
- Neuroscience Center, University of Pécs, 7624 Pécs, Hungary
| | - László Péczely
- Medical School, Institute of Physiology, University of Pécs, 7624 Pécs, Hungary; (O.K.); (D.V.); (K.M.); (T.O.); (L.P.); (A.K.); (O.Z.); (E.K.); (V.K.); (B.L.); (E.H.); (B.B.); (A.T.); (Z.K.); (L.L.)
- Neuroscience Center, University of Pécs, 7624 Pécs, Hungary
| | - Anita Kovács
- Medical School, Institute of Physiology, University of Pécs, 7624 Pécs, Hungary; (O.K.); (D.V.); (K.M.); (T.O.); (L.P.); (A.K.); (O.Z.); (E.K.); (V.K.); (B.L.); (E.H.); (B.B.); (A.T.); (Z.K.); (L.L.)
- Neuroscience Center, University of Pécs, 7624 Pécs, Hungary
| | - Olga Zagoracz
- Medical School, Institute of Physiology, University of Pécs, 7624 Pécs, Hungary; (O.K.); (D.V.); (K.M.); (T.O.); (L.P.); (A.K.); (O.Z.); (E.K.); (V.K.); (B.L.); (E.H.); (B.B.); (A.T.); (Z.K.); (L.L.)
- Neuroscience Center, University of Pécs, 7624 Pécs, Hungary
| | - Erika Kertes
- Medical School, Institute of Physiology, University of Pécs, 7624 Pécs, Hungary; (O.K.); (D.V.); (K.M.); (T.O.); (L.P.); (A.K.); (O.Z.); (E.K.); (V.K.); (B.L.); (E.H.); (B.B.); (A.T.); (Z.K.); (L.L.)
- Neuroscience Center, University of Pécs, 7624 Pécs, Hungary
| | - Veronika Kállai
- Medical School, Institute of Physiology, University of Pécs, 7624 Pécs, Hungary; (O.K.); (D.V.); (K.M.); (T.O.); (L.P.); (A.K.); (O.Z.); (E.K.); (V.K.); (B.L.); (E.H.); (B.B.); (A.T.); (Z.K.); (L.L.)
- Neuroscience Center, University of Pécs, 7624 Pécs, Hungary
| | - Bettina László
- Medical School, Institute of Physiology, University of Pécs, 7624 Pécs, Hungary; (O.K.); (D.V.); (K.M.); (T.O.); (L.P.); (A.K.); (O.Z.); (E.K.); (V.K.); (B.L.); (E.H.); (B.B.); (A.T.); (Z.K.); (L.L.)
- Neuroscience Center, University of Pécs, 7624 Pécs, Hungary
| | - Edina Hormay
- Medical School, Institute of Physiology, University of Pécs, 7624 Pécs, Hungary; (O.K.); (D.V.); (K.M.); (T.O.); (L.P.); (A.K.); (O.Z.); (E.K.); (V.K.); (B.L.); (E.H.); (B.B.); (A.T.); (Z.K.); (L.L.)
- Neuroscience Center, University of Pécs, 7624 Pécs, Hungary
| | - Beáta Berta
- Medical School, Institute of Physiology, University of Pécs, 7624 Pécs, Hungary; (O.K.); (D.V.); (K.M.); (T.O.); (L.P.); (A.K.); (O.Z.); (E.K.); (V.K.); (B.L.); (E.H.); (B.B.); (A.T.); (Z.K.); (L.L.)
- Neuroscience Center, University of Pécs, 7624 Pécs, Hungary
| | - Attila Tóth
- Medical School, Institute of Physiology, University of Pécs, 7624 Pécs, Hungary; (O.K.); (D.V.); (K.M.); (T.O.); (L.P.); (A.K.); (O.Z.); (E.K.); (V.K.); (B.L.); (E.H.); (B.B.); (A.T.); (Z.K.); (L.L.)
- Neuroscience Center, University of Pécs, 7624 Pécs, Hungary
| | - Zoltán Karádi
- Medical School, Institute of Physiology, University of Pécs, 7624 Pécs, Hungary; (O.K.); (D.V.); (K.M.); (T.O.); (L.P.); (A.K.); (O.Z.); (E.K.); (V.K.); (B.L.); (E.H.); (B.B.); (A.T.); (Z.K.); (L.L.)
- Neuroscience Center, University of Pécs, 7624 Pécs, Hungary
- Szentágothai Center, Molecular Endocrinology and Neurophysiology Research Group, University of Pécs, 7624 Pécs, Hungary
| | - László Lénárd
- Medical School, Institute of Physiology, University of Pécs, 7624 Pécs, Hungary; (O.K.); (D.V.); (K.M.); (T.O.); (L.P.); (A.K.); (O.Z.); (E.K.); (V.K.); (B.L.); (E.H.); (B.B.); (A.T.); (Z.K.); (L.L.)
- Neuroscience Center, University of Pécs, 7624 Pécs, Hungary
- Szentágothai Center, Molecular Endocrinology and Neurophysiology Research Group, University of Pécs, 7624 Pécs, Hungary
| |
Collapse
|
6
|
Péczely L, Kékesi G, Kállai V, Ollmann T, László K, Büki A, Lénárd L, Horváth G. Effects of D 2 dopamine receptor activation in the ventral pallidum on sensory gating and food-motivated learning in control and schizophrenia model (Wisket) rats. Behav Brain Res 2020; 400:113047. [PMID: 33279633 DOI: 10.1016/j.bbr.2020.113047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2020] [Revised: 11/24/2020] [Accepted: 11/25/2020] [Indexed: 11/28/2022]
Abstract
Dopamine D2 receptors (D2Rs) of the ventral pallidum (VP) play important role in motivational and learning processes, however, their potential role in triggering schizophrenic symptoms has not been investigated, yet. In the present experiments the effects of locally administered D2R agonist quinpirole were investigated on behavioral parameters related to sensorimotor gating, motor activity and food-motivated labyrinth learning. Two weeks after bilateral implantation of microcannulae into the VP, the acute (30 min) and delayed (3, 21 and 24 h) effects of quinpirole microinjection (1 μg/0.4 μL at both sides) were investigated in Wistar and schizophrenia model (Wisket substrain) rats in prepulse inhibition (PPI) and the reward-based Ambitus tests. Quinpirole administration did not modify the impaired sensorimotor gating in Wisket rats, but it led to significant deficit in Wistar animals. Regarding the locomotor activity in the Ambitus test, no effects of quinpirole were detected in either groups at the investigated time points. In contrast, quinpirole resulted in decreased exploratory and food-collecting activities in Wistar rats with 21 and 24 h delay. Though, impaired food-related motivation could be observed in Wisket rats, but quinpirole treatment did not result in further deterioration. In summary, our results showed that the VP D2R activation in Wistar rats induces symptoms similar to those observed in schizophrenia model Wisket rats. These data suggest that Wisket rats might have significant alterations in the functional activity of VP, which might be due to its enhanced dopaminergic activity.
Collapse
Affiliation(s)
- László Péczely
- Institute of Physiology, Faculty of Medicine, University of Pécs, Pécs, Hungary; Centre for Neuroscience, Pécs University, Pécs, Hungary.
| | - Gabriella Kékesi
- Department of Physiology, Faculty of Medicine, University of Szeged, Szeged, Hungary
| | - Veronika Kállai
- Institute of Physiology, Faculty of Medicine, University of Pécs, Pécs, Hungary; Centre for Neuroscience, Pécs University, Pécs, Hungary
| | - Tamás Ollmann
- Institute of Physiology, Faculty of Medicine, University of Pécs, Pécs, Hungary; Centre for Neuroscience, Pécs University, Pécs, Hungary
| | - Kristóf László
- Institute of Physiology, Faculty of Medicine, University of Pécs, Pécs, Hungary; Centre for Neuroscience, Pécs University, Pécs, Hungary
| | - Alexandra Büki
- Department of Physiology, Faculty of Medicine, University of Szeged, Szeged, Hungary
| | - László Lénárd
- Institute of Physiology, Faculty of Medicine, University of Pécs, Pécs, Hungary; Molecular Neuroendocrinology and Neurophysiology Research Group, Szentágothai Research Centre, Pécs University, Pécs, Hungary; Centre for Neuroscience, Pécs University, Pécs, Hungary
| | - Gyöngyi Horváth
- Department of Physiology, Faculty of Medicine, University of Szeged, Szeged, Hungary
| |
Collapse
|
7
|
László K, Péczely L, Géczi F, Kovács A, Zagoracz O, Ollmann T, Kertes E, Kállai V, László B, Berta B, Karádi Z, Lénárd L. The role of D2 dopamine receptors in oxytocin induced place preference and anxiolytic effect. Horm Behav 2020; 124:104777. [PMID: 32439347 DOI: 10.1016/j.yhbeh.2020.104777] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/03/2020] [Revised: 04/24/2020] [Accepted: 05/15/2020] [Indexed: 12/01/2022]
Abstract
Neuropeptide oxytocin (OT) is involved in the regulation of social and non-social behaviour. The central nucleus of amygdala (CeA), part of the limbic system, plays an important role in learning, memory, anxiety and reinforcing mechanisms. CeA has been shown to be rich in OT receptors in rodents. Our previous findings indicated that OT in the rat CeA has a dose dependent rewarding and anxiolytic effect. The aim of our present study was to examine in the CeA the possible interaction of OT and D2 dopamine (DA) receptor antagonist Sulpiride on reinforcement in place preference test and on anxiety in elevated plus maze test. Wistar rats were microinjected bilaterally with 10 ng OT. In different group of animals 4 μg D2 DA receptor antagonist was applied. Other animals received D2 DA receptor antagonist 15 min before 10 ng OT treatment or vehicle solution into the CeA. Rats receiving 10 ng OT spent significantly longer time in the treatment quadrant during the test session in conditioned place preference test. Prior treatment with D2 DA receptor antagonist blocked the rewarding effects of OT. Antagonist in itself did not influence the time rats spent in the treatment quadrant. In elevated plus maze test, rats receiving 10 ng OT spent significantly longer time on the open arms. Prior treatment with D2 DA receptor antagonist blocked the effects of OT. Our results show that DA system plays a role in positive reinforcing and anxiolytic effects of OT because D2 DA receptor antagonist can block these actions.
Collapse
MESH Headings
- Amygdala/drug effects
- Amygdala/metabolism
- Animals
- Anti-Anxiety Agents/pharmacology
- Anxiety/drug therapy
- Behavior, Animal/drug effects
- Conditioning, Classical/drug effects
- Dopamine D2 Receptor Antagonists/pharmacology
- Fear/drug effects
- Freezing Reaction, Cataleptic/drug effects
- Male
- Maze Learning/drug effects
- Oxytocin/pharmacology
- Rats
- Rats, Wistar
- Receptors, Dopamine D1/metabolism
- Receptors, Dopamine D2/metabolism
- Receptors, Dopamine D2/physiology
- Receptors, Oxytocin/metabolism
- Receptors, Oxytocin/physiology
- Reinforcement, Psychology
- Reward
- Spatial Behavior/drug effects
- Sulpiride/pharmacology
Collapse
Affiliation(s)
- K László
- Institute of Physiology, University of Pécs, Medical School, Pécs, Hungary; Neuroscience Center, University of Pécs, Pécs, Hungary.
| | - L Péczely
- Institute of Physiology, University of Pécs, Medical School, Pécs, Hungary; Neuroscience Center, University of Pécs, Pécs, Hungary
| | - F Géczi
- Institute of Physiology, University of Pécs, Medical School, Pécs, Hungary; Neuroscience Center, University of Pécs, Pécs, Hungary
| | - A Kovács
- Institute of Physiology, University of Pécs, Medical School, Pécs, Hungary; Neuroscience Center, University of Pécs, Pécs, Hungary
| | - O Zagoracz
- Institute of Physiology, University of Pécs, Medical School, Pécs, Hungary; Neuroscience Center, University of Pécs, Pécs, Hungary
| | - T Ollmann
- Institute of Physiology, University of Pécs, Medical School, Pécs, Hungary; Neuroscience Center, University of Pécs, Pécs, Hungary
| | - E Kertes
- Institute of Physiology, University of Pécs, Medical School, Pécs, Hungary; Neuroscience Center, University of Pécs, Pécs, Hungary
| | - V Kállai
- Institute of Physiology, University of Pécs, Medical School, Pécs, Hungary; Neuroscience Center, University of Pécs, Pécs, Hungary
| | - B László
- Institute of Physiology, University of Pécs, Medical School, Pécs, Hungary; Neuroscience Center, University of Pécs, Pécs, Hungary
| | - B Berta
- Institute of Physiology, University of Pécs, Medical School, Pécs, Hungary; Neuroscience Center, University of Pécs, Pécs, Hungary
| | - Z Karádi
- Institute of Physiology, University of Pécs, Medical School, Pécs, Hungary; Neuroscience Center, University of Pécs, Pécs, Hungary; Molecular Endocrinology and Neurophysiology Research Group, University of Pécs, Szentágothai Center, Pécs, Hungary
| | - L Lénárd
- Institute of Physiology, University of Pécs, Medical School, Pécs, Hungary; Neuroscience Center, University of Pécs, Pécs, Hungary; Molecular Endocrinology and Neurophysiology Research Group, University of Pécs, Szentágothai Center, Pécs, Hungary
| |
Collapse
|
8
|
Kállai V, Lénárd L, Péczely L, Gálosi R, Dusa D, Tóth A, László K, Kertes E, Kovács A, Zagoracz O, Berta B, Karádi Z, Ollmann T. Cognitive performance of the MAM-E17 schizophrenia model rats in different age-periods. Behav Brain Res 2020; 379:112345. [PMID: 31704232 DOI: 10.1016/j.bbr.2019.112345] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2019] [Revised: 10/03/2019] [Accepted: 11/04/2019] [Indexed: 11/17/2022]
Abstract
Cognitive disturbances are among the most important features of schizophrenia, and have a significant role in the outcome of the disease. However, the treatment of cognitive symptoms is poorly effective. In order to develop new therapeutic opportunities, the MAM-E17 rat model of schizophrenia can be an appropriate implement. In the present study we investigated several cognitive capabilities of MAM-treated rats using radial arm maze (RAM) task, which corresponds to the recent research directives. Because of the diachronic appearance of schizophrenia symptoms and the early appearance of cognitive deficiencies, we carried out our experiments in three different age-periods of rats, i.e. in prepuberty, late puberty and adulthood. The performance of MAM-E17 rats was similar to control rats in the acquisition phase of RAM task, except for puberty. However, after rearrangement of reward positions (in the reverse paradigm) the number of errors of MAM-treated rats was higher in each age-period. In the reverse paradigm MAM-treated groups visited more frequently those non-rewarding arms, which were previously rewarding. Our results suggest that working memory of MAM-E17 rats is impaired. This deficit depends on the difficulty of the task and on the age-period. MAM-E17 rats seem to be more sensitive in puberty in comparison to controls. Diminished behavioral flexibility was shown as well. These behavioral results observed in MAM-E17 rats were similar to those of cognitive deficiencies in schizophrenia patients. Therefore, MAM-E17 model can be a useful implement for further research aiming to improve cognition in schizophrenia.
Collapse
Affiliation(s)
- Veronika Kállai
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Centre for Neuroscience, Pécs University, Pécs, Hungary
| | - László Lénárd
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Molecular Neuroendocrinology and Neurophysiology Research Group, Szentágothai Research Centre, Pécs University, Pécs, Hungary; Centre for Neuroscience, Pécs University, Pécs, Hungary.
| | - László Péczely
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Centre for Neuroscience, Pécs University, Pécs, Hungary
| | - Rita Gálosi
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Centre for Neuroscience, Pécs University, Pécs, Hungary
| | - Daniella Dusa
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Centre for Neuroscience, Pécs University, Pécs, Hungary
| | - Attila Tóth
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Centre for Neuroscience, Pécs University, Pécs, Hungary
| | - Kristóf László
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Centre for Neuroscience, Pécs University, Pécs, Hungary
| | - Erika Kertes
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Centre for Neuroscience, Pécs University, Pécs, Hungary
| | - Anita Kovács
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Centre for Neuroscience, Pécs University, Pécs, Hungary
| | - Olga Zagoracz
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Centre for Neuroscience, Pécs University, Pécs, Hungary
| | - Beáta Berta
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Centre for Neuroscience, Pécs University, Pécs, Hungary
| | - Zoltán Karádi
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Molecular Neuroendocrinology and Neurophysiology Research Group, Szentágothai Research Centre, Pécs University, Pécs, Hungary; Centre for Neuroscience, Pécs University, Pécs, Hungary
| | - Tamás Ollmann
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Centre for Neuroscience, Pécs University, Pécs, Hungary
| |
Collapse
|
9
|
Zagorácz O, Ollmann T, Péczely L, László K, Kovács A, Berta B, Kállai V, Kertes E, Lénárd L. QRFP administration into the medial hypothalamic nuclei improves memory in rats. Brain Res 2019; 1727:146563. [PMID: 31765630 DOI: 10.1016/j.brainres.2019.146563] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2019] [Revised: 10/31/2019] [Accepted: 11/19/2019] [Indexed: 10/25/2022]
Abstract
Even though several of RFamide peptides have been shown to modify memory and learning processes in different species, almost nothing is known regarding cognitive effects of recently discovered neuropeptide QRFP. Considering multiple physiological functions of QRFP, localization of QRFP-synthesizing neurons in the hypothalamus and its' widely spread binding sites within the CNS, the present study was designed to investigate the possible role of QRFP in the consolidation of spatial memory. As target area for microinjection, the medial hypothalamic area, including dorsomedial (DMN) and ventromedial (VMN) nuclei, has been chosen. At first, the effects of two doses (200 ng and 400 ng) of QRFP were investigated in Morris water maze. After that receptor antagonist BIBP3226 (equimolar amount to the effective dose of neuropeptide) was applied to elucidate whether it can prevent effects of QRFP. To reveal possible changes in anxiety level, animals were tested in Elevated plus maze. The higher dose of QRFP (400 ng) improved short-term memory consolidation in Morris water maze. Pretreatment with antagonist BIBP3226 abolished cognitive effects of QRFP. The neuropeptide did not affect anxiety level of rats. This study provides unique evidence regarding the role of QRFP in the consolidation of memory and gives the basis for further investigations of neuropeptide's cognitive effects.
Collapse
Affiliation(s)
- Olga Zagorácz
- Institute of Physiology, Pécs University Medical School, Pécs, Hungary
| | - Tamás Ollmann
- Institute of Physiology, Pécs University Medical School, Pécs, Hungary
| | - László Péczely
- Institute of Physiology, Pécs University Medical School, Pécs, Hungary
| | - Kristóf László
- Institute of Physiology, Pécs University Medical School, Pécs, Hungary
| | - Anita Kovács
- Institute of Physiology, Pécs University Medical School, Pécs, Hungary
| | - Beáta Berta
- Institute of Physiology, Pécs University Medical School, Pécs, Hungary
| | - Veronika Kállai
- Institute of Physiology, Pécs University Medical School, Pécs, Hungary
| | - Erika Kertes
- Institute of Physiology, Pécs University Medical School, Pécs, Hungary
| | - László Lénárd
- Institute of Physiology, Pécs University Medical School, Pécs, Hungary; Molecular Neurophysiology Research Group, Pécs University, Szentágothai Research Center, Pécs, Hungary.
| |
Collapse
|
10
|
Berta B, Kertes E, Péczely L, Ollmann T, László K, Gálosi R, Kállai V, Petykó Z, Zagorácz O, Kovács A, Karádi Z, Lénárd L. Ventromedial prefrontal cortex is involved in preference and hedonic evaluation of tastes. Behav Brain Res 2019; 367:149-157. [PMID: 30940513 DOI: 10.1016/j.bbr.2019.03.051] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2019] [Revised: 03/29/2019] [Accepted: 03/29/2019] [Indexed: 01/01/2023]
Abstract
The ventromedial prefrontal cortex (vmPFC) of rats has reciprocal connections with the gustatory and the hedonic impact coding structures. The main goal of the present study was to investigate the involvement of local neurons of vmPFC and their catecholaminergic innervations in taste preference and taste reactivity test. Therefore, kainate or 6-hydroxydopamine (6-OHDA) lesions were performed in the vmPFC by iontophoretic method. In the first experiment, taste preference was tested to 250 mM and 500 mM glucose solutions over water in two-bottle choice test. In the second experiment, taste reactivity was examined to 4 concentrations of glucose solutions (250 mM, 500 mM, 750 mM and 1000 mM) and 4 concentrations of quinine solutions (0.125 mM, 0.25 mM, 1.25 mM and 2.5 mM). Our results showed, that kainate microlesion of vmPFC did not modify the preference of 250 mM and 500 mM glucose solutions in two-bottle choice test. In contrast, 6-OHDA microlesion of vmPFC resulted in increased preference to the higher concentration of glucose (500 mM) solution over water. Results of taste reactivity test showed that kainate lesion resulted in more ingestive and less rejective responses to 750 mM glucose solution and elevated rejectivity to the higher concentrations (1.25 mM and 2.5 mM) of quinine solutions. 6-OHDA lesion of vmPFC increased the number of ingestive responses to highly concentrated (500 mM, 750 mM and 1000 mM) glucose solutions and decreased the number of ingestive responses to the lower concentration (0.125 mM) of quinine solution. The present data provide evidence for the important role of vmPFC neurons and catecholaminergic innervation of the vmPFC in the regulation of hedonic evaluation of tastes and in the hedonic consummatory behavior.
Collapse
Affiliation(s)
- Beáta Berta
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Neuroscience Center, Pécs University, Pécs, Hungary
| | - Erika Kertes
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Neuroscience Center, Pécs University, Pécs, Hungary
| | - László Péczely
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Neuroscience Center, Pécs University, Pécs, Hungary
| | - Tamás Ollmann
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Neuroscience Center, Pécs University, Pécs, Hungary
| | - Kristóf László
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Neuroscience Center, Pécs University, Pécs, Hungary
| | - Rita Gálosi
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Neuroscience Center, Pécs University, Pécs, Hungary
| | - Veronika Kállai
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Neuroscience Center, Pécs University, Pécs, Hungary
| | - Zoltán Petykó
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Neuroscience Center, Pécs University, Pécs, Hungary; Molecular Neuroendocrinology Research Group, Szentágothai Research Center, Pécs University, Pécs, Hungary
| | - Olga Zagorácz
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Neuroscience Center, Pécs University, Pécs, Hungary
| | - Anita Kovács
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Neuroscience Center, Pécs University, Pécs, Hungary
| | - Zoltán Karádi
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Neuroscience Center, Pécs University, Pécs, Hungary; Molecular Neuroendocrinology Research Group, Szentágothai Research Center, Pécs University, Pécs, Hungary
| | - László Lénárd
- Institute of Physiology, Medical School, Pécs University, Pécs, Hungary; Neuroscience Center, Pécs University, Pécs, Hungary; Molecular Neuroendocrinology Research Group, Szentágothai Research Center, Pécs University, Pécs, Hungary.
| |
Collapse
|
11
|
Berta B, Péczely L, Kertes E, Petykó Z, Ollmann T, László K, Kállai V, Kovács A, Zagorácz O, Gálosi R, Karádi Z, Lénárd L. Iontophoretic microlesions with kainate or 6-hydroxidopamine in ventromedial prefrontal cortex result in deficit in conditioned taste avoidance to palatable tastants. Brain Res Bull 2018; 143:106-115. [PMID: 30347263 DOI: 10.1016/j.brainresbull.2018.10.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2018] [Revised: 09/12/2018] [Accepted: 10/04/2018] [Indexed: 02/08/2023]
Abstract
Effects of kainate or 6-hydroxidopamine (6-OHDA) lesions in the ventromedial prefrontal cortex (vmPFC) on taste-related learning and memory processes were examined. Neurotoxins were applied by iontophoretic method to minimize the extent of lesion and the side effects. Acquisition and retention of conditioned taste avoidance (CTA) was tested to different taste stimuli (0.05 M NaCl, 0.01 M saccharin, 0.01 M citrate and 0.00025 M quinine). In the first experiment, palatability index of taste solutions with these concentrations has been determined as strongly palatable (NaCl, saccharin), weakly palatable (citrate) and weakly unpalatable (quinine) taste stimuli. In two other experiments vmPFC lesions were performed before CTA (acquisition) or after CTA (retrieval). Our results showed that both kainate and 6-OHDA microlesions of vmPFC resulted in deficit of CTA acquisition (to NaCl, saccharin and citrate) and retrieval (to NaCl and saccharin). Deficits were specific to palatable tastants, particularly those that are strongly palatable, and did not occur for unpalatable stimulus. The present data provide evidence for the important role of vmPFC neurons and catecholaminergic innervation of the vmPFC in taste related learning and memory processes.
Collapse
Affiliation(s)
- Beáta Berta
- Institute of Physiology, Medical School, Pécs University, Pécs Hungary; Neuroscience Center, Pécs University, Pécs, Hungary
| | - László Péczely
- Institute of Physiology, Medical School, Pécs University, Pécs Hungary; Neuroscience Center, Pécs University, Pécs, Hungary
| | - Erika Kertes
- Institute of Physiology, Medical School, Pécs University, Pécs Hungary; Neuroscience Center, Pécs University, Pécs, Hungary
| | - Zoltán Petykó
- Institute of Physiology, Medical School, Pécs University, Pécs Hungary; Neuroscience Center, Pécs University, Pécs, Hungary; Molecular Neuroendocrinology Research Group, Szentágothai Research Center, Pécs University, Pécs, Hungary
| | - Tamás Ollmann
- Institute of Physiology, Medical School, Pécs University, Pécs Hungary; Neuroscience Center, Pécs University, Pécs, Hungary
| | - Kristóf László
- Institute of Physiology, Medical School, Pécs University, Pécs Hungary; Neuroscience Center, Pécs University, Pécs, Hungary
| | - Veronika Kállai
- Institute of Physiology, Medical School, Pécs University, Pécs Hungary; Neuroscience Center, Pécs University, Pécs, Hungary
| | - Anita Kovács
- Institute of Physiology, Medical School, Pécs University, Pécs Hungary; Neuroscience Center, Pécs University, Pécs, Hungary
| | - Olga Zagorácz
- Institute of Physiology, Medical School, Pécs University, Pécs Hungary; Neuroscience Center, Pécs University, Pécs, Hungary
| | - Rita Gálosi
- Institute of Physiology, Medical School, Pécs University, Pécs Hungary; Neuroscience Center, Pécs University, Pécs, Hungary
| | - Zoltán Karádi
- Institute of Physiology, Medical School, Pécs University, Pécs Hungary; Neuroscience Center, Pécs University, Pécs, Hungary; Molecular Neuroendocrinology Research Group, Szentágothai Research Center, Pécs University, Pécs, Hungary
| | - László Lénárd
- Institute of Physiology, Medical School, Pécs University, Pécs Hungary; Neuroscience Center, Pécs University, Pécs, Hungary; Molecular Neuroendocrinology Research Group, Szentágothai Research Center, Pécs University, Pécs, Hungary.
| |
Collapse
|
12
|
Gálosi R, Petykó Z, Kállai V, Tóth A, Ollmann T, Péczely L, Kovács A, Berta B, Lénárd L. Destruction of noradrenergic terminals increases dopamine concentration and reduces dopamine metabolism in the medial prefrontal cortex. Behav Brain Res 2018; 344:57-64. [PMID: 29454007 DOI: 10.1016/j.bbr.2018.02.016] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2017] [Revised: 02/13/2018] [Accepted: 02/13/2018] [Indexed: 01/01/2023]
Abstract
Effects of destroyed noradrenergic (NE) innervation in the medial prefrontal cortex (mPFC) were examined on dopamine (DA) content and metabolism. Six-hydroxy-DOPA (6-OHDOPA) or 6-hydroxy-dopamine (6-OHDA) in combination with a potent DA reuptake inhibitor GBR 12935 or 6-OHDA were injected bilaterally into the mPFC in separate groups of animals. In addition, GBR 12935 or vehicle was injected into the mPFC in two other groups of animals as control experiments. NE and DA concentrations from postmortem tissue of the mPFC were measured using HPLC with electrochemical detection. In addition, extracellular NE, DA and DOPAC levels were determined using in vivo microdialysis after the 6-OHDA lesion in combination with GBR 12935 pretreatment in the mPFC. Using reverse microdialysis of alpha-2-adrenoreceptor antagonist yohimbine, we tested the remaining activity of NE innervation and the extracellular concentration of DA and DOPAC. NE and DA concentrations from postmortem tissue of the mPFC showed that 6-OHDOPA lesion reduced NE concentration to 76%, which was a non-significant alteration, however it enhanced significantly DA concentration to 186% compared to vehicle. After 6-OHDA lesion with GBR 12935 pretreatment, concentration of NE significantly decreased to 51% and DA level increased to 180%. 6-OHDA lesion without GBR 12635 pretreatment decreased NE concentration to 23% and DA concentration to 67%. In the microdialysis experiment, after 6-OHDA lesion with GBR 12935 pretreatment, extracellular NE levels were not detectable, whereas extracellular DA levels were increased and DOPAC levels were decreased compared to controls. Reverse microdialysis of yohimbine demonstrated that the residual NE innervation was able to increase NE level and DA levels, but DOPAC concentration remained low after lesion of the NE terminals. These findings suggest that the damage of NE innervation in the mPFC may alter extracellular DA level due to a reduced DA clearance.
Collapse
Affiliation(s)
- Rita Gálosi
- Institute of Physiology, University of Pécs Medical School, Pécs, Hungary.
| | - Zoltán Petykó
- Institute of Physiology, University of Pécs Medical School, Pécs, Hungary; Molecular Neuroendocrinology Research Group, University of Pécs, Szentágothai Research Center, Pécs, Hungary
| | - Veronika Kállai
- Institute of Physiology, University of Pécs Medical School, Pécs, Hungary
| | - Attila Tóth
- Institute of Physiology, University of Pécs Medical School, Pécs, Hungary
| | - Tamás Ollmann
- Institute of Physiology, University of Pécs Medical School, Pécs, Hungary
| | - László Péczely
- Institute of Physiology, University of Pécs Medical School, Pécs, Hungary
| | - Anita Kovács
- Institute of Physiology, University of Pécs Medical School, Pécs, Hungary
| | - Beáta Berta
- Institute of Physiology, University of Pécs Medical School, Pécs, Hungary
| | - László Lénárd
- Institute of Physiology, University of Pécs Medical School, Pécs, Hungary; Molecular Neuroendocrinology Research Group, University of Pécs, Szentágothai Research Center, Pécs, Hungary
| |
Collapse
|
13
|
Lénárd L, László K, Kertes E, Ollmann T, Péczely L, Kovács A, Kállai V, Zagorácz O, Gálosi R, Karádi Z. Substance P and neurotensin in the limbic system: Their roles in reinforcement and memory consolidation. Neurosci Biobehav Rev 2018; 85:1-20. [DOI: 10.1016/j.neubiorev.2017.09.003] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2017] [Revised: 08/24/2017] [Accepted: 09/02/2017] [Indexed: 12/18/2022]
|
14
|
Kállai V, Tóth A, Gálosi R, Péczely L, Ollmann T, Petykó Z, László K, Kállai J, Szabó I, Karádi Z, Lénárd L. The MAM-E17 schizophrenia rat model: Comprehensive behavioral analysis of pre-pubertal, pubertal and adult rats. Behav Brain Res 2017; 332:75-83. [DOI: 10.1016/j.bbr.2017.05.065] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2017] [Revised: 05/26/2017] [Accepted: 05/28/2017] [Indexed: 01/17/2023]
|
15
|
Tóth A, Petykó Z, Gálosi R, Szabó I, Karádi K, Feldmann Á, Péczely L, Kállai V, Karádi Z, Lénárd L. Neuronal coding of auditory sensorimotor gating in medial prefrontal cortex. Behav Brain Res 2017; 326:200-208. [PMID: 28284946 DOI: 10.1016/j.bbr.2017.03.004] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2016] [Revised: 02/26/2017] [Accepted: 03/02/2017] [Indexed: 12/22/2022]
Abstract
The medial prefrontal cortex (mPFC) is thought to be an essential brain region for sensorimotor gating. The exact neuronal mechanisms, however, have not been extensively investigated yet by delicate single unit recording methods Prepulse inhibition (PPI) of the startle response is a broadly used important tool to investigate the inhibitory processes of sensorimotor gating. The present study was designed to examine the neuronal mechanisms of sensorimotor gating in the mPFC in freely moving rats. In these experiments, the animals were subjected to both pulse alone and prepulse+pulse stimulations. Head acceleration and the neuronal activity of the mPFC were simultaneously recorded. To adequately measure the startle reflex, a new headstage with 3D-accelerometer was created. The duration of head acceleration was longer in pulse alone trials than in prepulse+pulse trial conditions, and the amplitude of head movements was significantly larger during the pulse alone than during the prepulse+pulse situations. Single unit activities in the mPFC were recorded by means of chronically implanted tetrodes during acoustic stimulation evoked startle response and PPI. High proportion of medial prefrontal cortical neurons responded to these stimulations by characteristic firing patterns: short duration equal and unequal excitatory, medium duration excitatory, and long duration excitatory and inhibitory responses were recorded. The present findings, first time in the literature, demonstrated the startle and PPI elicited neuronal activity changes of the mPFC, and thus, provided evidence for a key role of this limbic forebrain area in sensorimotor gating process.
Collapse
Affiliation(s)
- Attila Tóth
- Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary; Centre for Neuroscience, University of Pécs, Pécs, Hungary
| | - Zoltán Petykó
- Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary; Centre for Neuroscience, University of Pécs, Pécs, Hungary; Molecular Neuroendocrinology and Neurophysiology Research Group, University of Pécs, Szentágothai Research Center, Pécs, Hungary
| | - Rita Gálosi
- Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary; Centre for Neuroscience, University of Pécs, Pécs, Hungary
| | - Imre Szabó
- Institute of Behavioral Sciences, Medical School, University of Pécs, Pécs, Hungary
| | - Kázmér Karádi
- Institute of Behavioral Sciences, Medical School, University of Pécs, Pécs, Hungary
| | - Ádám Feldmann
- Institute of Behavioral Sciences, Medical School, University of Pécs, Pécs, Hungary
| | - László Péczely
- Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary; Centre for Neuroscience, University of Pécs, Pécs, Hungary
| | - Veronika Kállai
- Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary; Centre for Neuroscience, University of Pécs, Pécs, Hungary
| | - Zoltán Karádi
- Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary; Centre for Neuroscience, University of Pécs, Pécs, Hungary; Molecular Neuroendocrinology and Neurophysiology Research Group, University of Pécs, Szentágothai Research Center, Pécs, Hungary
| | - László Lénárd
- Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary; Centre for Neuroscience, University of Pécs, Pécs, Hungary; Molecular Neuroendocrinology and Neurophysiology Research Group, University of Pécs, Szentágothai Research Center, Pécs, Hungary.
| |
Collapse
|
16
|
Ollmann T, Péczely L, László K, Kovács A, Gálosi R, Kertes E, Kállai V, Zagorácz O, Karádi Z, Lénárd L. Anxiolytic effect of neurotensin microinjection into the ventral pallidum. Behav Brain Res 2015; 294:208-14. [PMID: 26296669 DOI: 10.1016/j.bbr.2015.08.010] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2015] [Revised: 08/10/2015] [Accepted: 08/13/2015] [Indexed: 01/31/2023]
Abstract
Neurotensin (NT) acts as a neurotransmitter and neuromodulator in the central nervous system. NT is involved in reward and memory processes, drug addiction and also in the regulation of anxiety. The ventral pallidum (VP) receives neurotensinergic innervation from the ventral striatopallidal pathway originating from the nucleus accumbens. Positive reinforcing effects of NT in the VP had been shown recently, however the possible effects of NT on anxiety have not been examined yet. In our present experiments, the effects of NT on anxiety were investigated in the VP. In male Wistar rats bilateral microinjections of 100 ng or 250 ng NT were delivered in the volume of 0.4 μl into the VP, and elevated plus maze (EPM) test was performed. In another groups of animals, 35 ng NT-receptor 1 (NTR1) antagonist SR 48,692 was applied by itself, or microinjected 15 min before 100 ng NT treatment. Open field test (OPF) was also conducted. The 100 ng dose of NT had anxiolytic effect, but the 250 ng NT did not influence anxiety. The antagonist pretreatment inhibited the effect of NT, while the antagonist itself had no effect. In the OPF test there was no difference among the groups. Our present results show that microinjection of NT into the VP induces anxiolytic effect, which is specific to the NTR1 receptors because it can be eliminated by a specific NTR1 antagonist. It is also substantiated that neither the NT, nor the NTR1 antagonist in the VP influences locomotor activity.
Collapse
Affiliation(s)
- Tamás Ollmann
- Institute of Physiology, Pécs University, Medical School, Pécs, Hungary
| | - László Péczely
- Institute of Physiology, Pécs University, Medical School, Pécs, Hungary
| | - Kristóf László
- Institute of Physiology, Pécs University, Medical School, Pécs, Hungary
| | - Anita Kovács
- Institute of Physiology, Pécs University, Medical School, Pécs, Hungary
| | - Rita Gálosi
- Institute of Physiology, Pécs University, Medical School, Pécs, Hungary
| | - Erika Kertes
- Institute of Physiology, Pécs University, Medical School, Pécs, Hungary
| | - Veronika Kállai
- Institute of Physiology, Pécs University, Medical School, Pécs, Hungary
| | - Olga Zagorácz
- Institute of Physiology, Pécs University, Medical School, Pécs, Hungary
| | - Zoltán Karádi
- Institute of Physiology, Pécs University, Medical School, Pécs, Hungary; Molecular Neuroendocrinology and Neurophysiology Research Group, Pécs University, Szentágothai Center, Pécs, Hungary
| | - László Lénárd
- Institute of Physiology, Pécs University, Medical School, Pécs, Hungary; Molecular Neuroendocrinology and Neurophysiology Research Group, Pécs University, Szentágothai Center, Pécs, Hungary.
| |
Collapse
|
17
|
Kállai V, Tóth A, Gálosi R, Szabó I, Petykó Z, Karádi Z, Kállai J, Lénárd L. [MAM-E17 schizophrenia rat model]. Psychiatr Hung 2015; 30:4-17. [PMID: 25867884] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
Schizophrenia is a serious neuropsychiatric disorder. Several brain structures, neurotransmitter systems, genetic and environmental risk factors are suspected in the background. Because of its complexity the mechanism of the disorder is not known exactly, so the treatment of patients is unsolved. In the research of schizophrenia application of the rodent models is widespread. In this study one of these models based on the effect of methylazoxymethanol- acetate (MAM) is described, which is a neurodevelopmental, validated rat model. This antimitotic agent is able to evoke a number of schizophrenic symptomes temporarily disrupting the prenatal neurogenesis. The model reproduces numerous histological and neurophysiological changes of the human disorder, moreover it also represents several behavioral and cognitive phenomena resembling those in schizophrenia. A salient advantage of the model is the demonstration of the diachronic feature of the disorder, that is, postpubertal appearance of the positive symptoms. This model provides widespread opportunities for manipulations of the symptoms, so that using it in the future investigations can lead to a better understanding of this disorder.
Collapse
|
18
|
Koszegi Z, Kovács P, Wilhelm M, Atlasz T, Babai N, Kállai V, Hernádi I. The application of in vivo microiontophoresis for the investigation of mast cell-neuron interactions in the rat brain. ACTA ACUST UNITED AC 2006; 69:227-31. [PMID: 16707161 DOI: 10.1016/j.jbbm.2006.03.009] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2005] [Revised: 03/09/2006] [Accepted: 03/14/2006] [Indexed: 10/24/2022]
Abstract
Although mast cells are immune cells of hematopoietic origin, they can be found in parts of the central nervous system of many mammalian species. In the rat brain they are located in the thalamic region. Their function is not defined yet, although they are mostly known to secrete several chemicals, which may influence the surrounding neurons. There are no in vivo electrophysiological data available on the possible effects of brain mast cells on neurons. In this study, we used a combined method of microiontophoresis and extracellular single unit recording to simultaneously activate mast cells and record neuronal action potentials. Four-barrelled micropipettes were used for recording neuronal activity and for microiontophoretic application of mast cell degranulator Compound 48/80 (C48/80). Spike sorting routines were performed on-line and off-line to ensure that data were always recorded from a single neuron. C48/80 did not modify the firing rate of cortical neurons (no mast cells are found there), however, it caused excitation (n = 16/37, 43%), or inhibition (n = 9/37, 24%) in thalamic neurons possibly due to mast cell activation. Further investigations will clarify the biochemical nature of changes in neural excitability due to mast cell degranulation in the mammalian brain.
Collapse
Affiliation(s)
- Zsombor Koszegi
- University of Pécs, Department of Experimental Zoology and Neurobiology, 6 Ifjúság street, H-7624, Pécs, Hungary
| | | | | | | | | | | | | |
Collapse
|